Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome
Objective: To formally characterize the evolving spectrum of movement disorders associated with chromosome 22q11.2 deletion syndrome Background: Emerging evidence suggests that a wide range of…Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study
Objective: To identify rare genetic variants in genes, previously associated with Parkinson’s disease (PD) within a population consisting of individuals with PD and unaffected controls…Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study
Objective: To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…Comparative study of Non-Motor Symptoms and it’s correlation with Quality of Life in Parkinson’s disease and Atypical Parkinsonism
Objective: The present study aimed to evaluate and compare the non-motor symptoms and their correlation with quality of life in patients with PD and AP.…monogenic parkinson´s disease in a chilean cohort
Objective: To describe the minimum prevalence and distribution of monogenic forms of PD in a chilean cohort Background: About 3–5% of Parkinson’s disease (PD) patients…Movement disorders in osmotic demyelination syndrome: A case series from a tertiary care centre
Objective: To assess the radiological and clinical features and characterize the various movement disorders in patients with osmotic demyelination syndrome. Background: Osmotic demyelination syndrome (ODS)…Validation of a Remote Patient Monitoring System for Parkinson Symptom Severity
Objective: To evaluate the feasibility of building a remote patient monitoring (RPM) system for measuring Parkinson symptom severity. Background: The characteristic objective measures (tremor, rigidity,…Early-phase 18F-FP-CIT PET images: a promising imaging biomarker for predicting early dementia conversion in Parkinson’s disease
Objective: This study aims to investigate whether early-phase 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images (i.e., images acquired within the first 10 min after…Navigating Open Science in Canada with the Canadian Open Parkinson Network
Objective: The Canadian Open Parkinson Network (C-OPN) is a pan-Canadian initiative that bridges people, data and resources to accelerate new discoveries in the field of…The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis
Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 405
- Next Page »